These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 38077402)

  • 1. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system.
    Calvillo-Rodríguez KM; Lorenzo-Anota HY; Rodríguez-Padilla C; Martínez-Torres AC; Scott-Algara D
    Front Immunol; 2023; 14():1294434. PubMed ID: 38077402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers.
    Chiaravalli M; Spring A; Agostini A; Piro G; Carbone C; Tortora G
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
    Yu S; Xiao H; Ma L; Zhang J; Zhang J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy.
    Palanivelu L; Liu CH; Lin LT
    Front Immunol; 2022; 13():1038226. PubMed ID: 36755812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbes mediated immunogenic cell death in cancer immunotherapy.
    Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
    Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
    Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
    Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
    Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
    Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenic cell death in hematological malignancies].
    Matsushita M
    Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.
    van Vloten JP; Workenhe ST; Wootton SK; Mossman KL; Bridle BW
    J Immunol; 2018 Jan; 200(2):450-458. PubMed ID: 29311387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment.
    Wang J; Ma J; Tai Z; Li L; Zhang T; Cheng T; Yu J; Zhu Q; Bao L; Chen Z
    Int J Nanomedicine; 2023; 18():7149-7172. PubMed ID: 38059000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment.
    Yang LJ; Han T; Liu RN; Shi SM; Luan SY; Meng SN
    Biomed Pharmacother; 2024 Aug; 177():117099. PubMed ID: 38981240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Sep; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
    Aria H; Rezaei M
    Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inducers of immunogenic cell death for tumor immunotherapy.
    Li X
    Tumori; 2018; 104(1):1-8. PubMed ID: 28967094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer.
    Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M
    Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
    Hiep Tran T; Thu Phuong Tran T
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113085. PubMed ID: 39276455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.